
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)


- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)

(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: CUPR (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -78.33% | Avg. Invested days 48 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() | ![]() |
Key Highlights
Company Size ETF | Market Capitalization 0 USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 3.51 - 6.98 | Updated Date 06/12/2025 |
52 Weeks Range 3.51 - 6.98 | Updated Date 06/12/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) - |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE - | Forward PE - | Enterprise Value - | Price to Sales(TTM) - |
Enterprise Value - | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA - | Shares Outstanding - | Shares Floating - |
Shares Outstanding - | Shares Floating - | ||
Percent Insiders - | Percent Institutions - |
Upturn AI SWOT
Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Company Overview
History and Background
Cuprina Holdings (Cayman) Limited is a holding company, typically used as a structure for foreign entities to list on US exchanges. It doesn't have a substantial operating history independent of its subsidiaries. Specific founding year and milestones depend on the underlying operating company it represents.
Core Business Areas
- Primary Operating Business: This segment encapsulates the core business of the operating company. Details are entirely dependent on which operating business is underneath.
Leadership and Structure
Leadership and structure are determined by the underlying operating company. The holding company structure itself primarily provides legal and regulatory advantages for listing on US exchanges.
Top Products and Market Share
Key Offerings
- Main Products: The products are dictated by the underlying operating company that Cuprina Holdings represents. Competitor analysis requires identifying the specific sector and companies.
Market Dynamics
Industry Overview
Industry overview depends entirely on the sector of the underlying operating company.
Positioning
Positioning depends entirely on the sector of the underlying operating company, no information provided.
Total Addressable Market (TAM)
Total Addressable Market (TAM) depends entirely on the sector of the underlying operating company.
Upturn SWOT Analysis
Strengths
- Access to US capital markets
- Potentially favorable tax structure through Cayman Islands
- Operating company specific strengths
- Streamlined listing process
Weaknesses
- Holding company structure adds complexity
- Increased regulatory scrutiny due to foreign entity status
- Dependence on the performance of the underlying operating company
- Potential for conflicts of interest between holding company and operating company management
Opportunities
- Expansion into new markets using US capital
- Acquisitions funded by US-listed equity
- Enhanced brand recognition and investor confidence
- Improved access to talent and partnerships
Threats
- Changes in US regulations regarding foreign listings
- Geopolitical risks affecting the operating company's home country
- Currency fluctuations impacting financial performance
- Increased competition from US-based companies
Competitors and Market Share
Key Competitors
Competitive Landscape
Competitive landscape depends on the underlying operating company's sector and competitors.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is entirely dependent on the underlying operating company. No data is provided as the value of Cuprina Holdings is only the value of its operations.
Future Projections: Future projections are entirely dependent on the underlying operating company and analyst estimates. No data is provided as the value of Cuprina Holdings is only the value of its operations.
Recent Initiatives: Recent initiatives are entirely dependent on the underlying operating company. No data is provided as the value of Cuprina Holdings is only the value of its operations.
Summary
Cuprina Holdings is a holding company; its strength hinges on the underlying operating business. Its success relies on the operating company's ability to execute and navigate its respective market. Regulatory changes and geopolitical risks associated with foreign listings pose potential threats. Investors should thoroughly research the operating company before investing.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Website (if the Operating business has one)
- Market Research Reports (for the underlying operating companies business)
Disclaimers:
This analysis is based on publicly available information and general holding company principles. The lack of visibility into the operating business limits comprehensive analysis. The information provided is not financial advice and should not be used as the sole basis for making investment decisions. Consult with a qualified financial advisor before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cuprina Holdings (Cayman) Limited Class A Ordinary Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2025-04-10 | CEO & Director Mr. Yong Qi Quek | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 14 | Website https://www.cuprina.com.sg |
Full time employees 14 | Website https://www.cuprina.com.sg |
Cuprina Holdings (Cayman) Limited, a biomedical and biotechnology company, focuses on the development and commercialization of products for the management of chronic wounds. The company manufactures and distributes a line of medical grade sterile blowfly larvae bio-dressing products used as a biological debridement tool for chronic wounds under the MEDIFLY brand name. It is also developing collagen dressings, including sponges, particles, and hydrogels using bullfrog collagen derived from the valorization of abattoir waste; and products using medical leeches for wound treatment. The company was founded in 2019 and is based in Singapore. Cuprina Holdings (Cayman) Limited operates as a subsidiary of Cuprina Holding Pte. Ltd.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.